(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 105.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.71%.
Scholar Rock Holding's revenue in 2025 is $0.On average, 15 Wall Street analysts forecast SRRK's revenue for 2025 to be $378,243,651, with the lowest SRRK revenue forecast at $0, and the highest SRRK revenue forecast at $2,356,372,257. On average, 15 Wall Street analysts forecast SRRK's revenue for 2026 to be $7,896,397,246, with the lowest SRRK revenue forecast at $789,843,740, and the highest SRRK revenue forecast at $14,138,233,540.
In 2027, SRRK is forecast to generate $27,887,818,669 in revenue, with the lowest revenue forecast at $15,994,769,258 and the highest revenue forecast at $42,200,484,961.